Zeiss 780 Upright Confocal

Zeiss 780 Upright Confocal

User Manual(s)

Location

MSRB3 - 4223

Capabilities

  • High sensitivity point scanning confocal imaging
  • Spectral array GaAsP detector
  • Upright motorized stage microscope
  • In vivo or in vitro samples
  • FCS

Cost

$34 per hour

Detailed Specifications

Microscope:

  • Zeiss Axio Examiner with fixed stage (mechanical)
  • 4 Objective turret
  • Metal halide fluorescence source for widefield eyepiece visualization
  • DAPI, Green, Red fluorescence cubes

Lasers:

  • 405 nm Diode laser
  • Argon/2 (458, 488, and 514nm lines available)
  • 561 nm Diode laser
  • HeNe 633nm

Objectives:

  • 2.5x/0.075 Dry EC Plan NeoFluar 440310-9903 WD 9.5 mm (normally in the drawer)
  • 5x/0.15 Dry Plan NeoFluar 440320 WD 18.5 mm (normally in the drawer)
  • 10x/0.45 Dry Zeiss Plan-Apochromat 1063-139 WD 2.0 mm
  • 20x/0.80 Dry Zeiss Plan-Apochromat 440640-9903 WD 0.55 mm
  • 20x/1.0 Water Zeiss W Plan-Apochromat 421452-9800 WD 1.8 mm
  • 63x/1.4 Oil Zeiss Plan-Apochromat 44 07 62 (02) WD 0.19 mm

Dichroic(s):

  • Twin gate dichroic system
  • Low angle of incidence for improved reflection suppression

Detectors:

  • 34 channel confocal detector array for versatilely
  • GaAsP high QE 32 channel spectral array with unmixing capability
  • 2 standard alkali PMTs in positions for blue and far-red detection
  • Photon counting possible with GaAsP array and PMT2 (cooled)
  • Transmitted light detector

Computer:

  • HP Z840 with Intel Xeon E5-2623 V3 3.00 Ghz processor, 16 GB RAM, 2TB data drive, 27" monitor
  • Windows 10 Enterprise (2015 LTSB) 64-bit
  • Zen 2.3 Black

 

Selected Publications

2026

  • Li Y, Bang S, Ji J, Xu J, Lee M, Chandra S, Serhan CN, Ji RR. Protectin DX resolves fracture-induced postoperative pain in mice via neuronal signaling and GPR37-activated macrophage efferocytosis. J Clin Invest. 2026 Jan 16;136(2):e190754. doi: 10.1172/JCI190754. PMID: 41542772; PMCID: PMC12807480.
  • Brown A, Strickland LM, Erman EN, Pirozzi CJ, Low JT, Diplas BH, Gibson E, Shobande M, Khambati T, Krylova M, Liu H, McLendon RE, Reitman ZJ, Keir ST, Zou L, Ashley DM, Waitkus MS. SMARCAL1 is a targetable synthetic lethal therapeutic vulnerability in ATRX-deficient gliomas that use Alternative Lengthening of Telomeres. Neuro Oncol. 2026 Jan 10:noaf300. doi: 10.1093/neuonc/noaf300. Epub ahead of print. PMID: 41520142.

2025